GELS.NASDAQGelteq LTD

F-1/A: Gelteq Limited Files Amendment No. 2 to Form F-1 Registration Statement for Proposed IPO

Sentiment:

Amendment to Registration Statement


Gelteq Limited has filed an amendment to its Form F-1 registration statement with the SEC, primarily to include certain exhibits related to its proposed initial public offering.

Capital raiseThe company proposes to issue and sell 1,300,000 ordinary shares.The underwriters have an option to purchase an additional 195,000 ordinary shares.The company previously closed a pre-IPO private placement, receiving gross proceeds of approximately AUD$1,431,161.The company has issued convertible notes in May 2023, February 2024 and May 2024 to raise capital.

Summary

  • Gelteq Limited, an Australian public limited company, filed Amendment No. 2 to its Form F-1 registration statement with the SEC on September 24, 2024.
  • The amendment primarily includes exhibits related to the proposed IPO.
  • The company intends to offer 1,300,000 ordinary shares, with an option for underwriters to purchase an additional 195,000 shares to cover over-allotments.
  • The registration statement includes details about indemnification of directors and officers, recent sales of unregistered securities, and various exhibits such as underwriting agreements, opinions of counsel, and material contracts.
  • Recent sales of unregistered securities include issuances of ordinary shares as part of acquisitions in June 2021, a pre-IPO private placement in September 2022 raising approximately AUD$1,431,161, and several convertible note offerings in 2023 and 2024.
  • The company has raised approximately AUD$1 million through the issuance of May 2024 Convertible Notes.
  • The company represents that it is not required to comply with the 12-month requirement in any other jurisdiction outside the United States and that complying with the 12-month requirement is impracticable or involves undue hardship.

Sentiment

Score: 6

Explanation: The document is primarily a regulatory filing, so the sentiment is neutral. The company is moving forward with its IPO plans, which is generally positive, but there are also risks and uncertainties associated with the offering.

Positives

  • The company is proceeding with its IPO plans, as evidenced by the filing of the amendment.
  • The inclusion of exhibits provides greater transparency and detail about the company's operations and agreements.
  • The company has secured underwriting arrangements with The Benchmark Company, LLC.
  • The company has obtained legal opinions regarding the validity of the ordinary shares and warrants being issued.

Negatives

  • The company has issued several convertible notes in recent years, which could potentially dilute existing shareholders upon conversion.
  • The company's expenses related to the offering are capped at $125,000, with legal expenses capped at $100,000, which could be a significant cost.
  • The company is relying on a representation that complying with the 12-month requirement is impracticable or involves undue hardship, which could raise concerns about the timeliness of its financial reporting.

Risks

  • The success of the IPO is subject to market conditions and investor demand.
  • The company's future performance is subject to various risks and uncertainties, as outlined in the registration statement.
  • The company's reliance on convertible note financing could create future financial obligations and potential dilution.
  • The company's ability to maintain compliance with regulatory requirements is crucial for the success of the offering and ongoing operations.

Future Outlook

The company intends to commence the proposed sale to the public as soon as practicable after the registration statement becomes effective.

Industry Context

The document does not provide specific industry context beyond the company's operations. Further research would be needed to assess the company's position relative to competitors and broader industry trends.

Stakeholder Impact

  • Shareholders may experience dilution upon the issuance of new shares and the conversion of convertible notes.
  • Employees may benefit from the company's growth and success following the IPO.
  • Customers and suppliers may see increased stability and investment in the company's products and services.
  • Creditors may be impacted by the company's financial performance and ability to meet its obligations.

Next Steps

  • The company will file the Prospectus pursuant to Rule 424(b) within the prescribed time period.
  • The company will cooperate with the Representative in endeavoring to qualify the Offered Securities for sale under the securities laws of such jurisdictions.
  • The company will use commercially reasonable efforts to maintain the listing and the registration of the Ordinary Shares and the Ordinary Shares underlying the Underwriters Warrant on the Exchange for at least three (3) years from the date of this Agreement.

Key Dates

DateDescription
October 2018Gelteq was incorporated as a proprietary company limited by shares under the laws of Australia.
June 2021Issuance of Ordinary Shares as part of acquisitions of Nutrigel Unit Trust and Sport Supplements Unit Trust.
August 7, 2021Date of Entrusted Processing Contract by and among Labixiaoxin (Fujian) Foods Industrial Co., Ltd. and Gelteq Pty Ltd
August 24, 2021Date of Commissioned Processing Intellectual Property Power of Attorney Contract by and among Labixiaoxin (Fujian) Foods Industrial Co., Ltd. and Gelteq Pty Ltd
September 6, 2021Date of Consulting Agreement by and among Sosna & Co Inc. and Gelteq Pty Ltd
November 1, 2021Date of Master Services Agreement by and among Adjutor Healthcare Pty Ltd and Gelteq Pty Ltd
October 30, 2021Date of Agreement for the Provision of Office Space by and among Lifestyle Breakthrough Holdings Unit Trust and Gelteq Pty Ltd
January 20, 2022Date of Loan Agreement by and among ACK Pty Ltd ATF Markoff Super Fund No.2, Andrew Vukosav Super AC, B&M Givoni Pty Ltd ATF B & M Givoni Superannuation Fund, 3 Frogs In A Pond Pty Ltd ATF GPG Superannuation Fund, Jeffrey Olyniec, Juergen Rochert, KDC Investments Pty Ltd ATF Lieb Family Superannuation Fund and Gelteq Pty Ltd
January 31, 2022Date of Wasatch Contract Manufacturing Agreement by and among Wasatch Product Development LLC and Gelteq Pty Ltd
February 2022Effected a share split of the issued and outstanding Ordinary Shares of the Company on a 1 to 1050 basis.
May 26, 2022Gelteq Pty Ltd converted into a public company, becoming Gelteq Limited.
April 28, 2022Date of Executive Service Agreement by and among Simon Hayden Szewach and Gelteq Pty Ltd
April 28, 2022Date of Executive Service Agreement by and among Nathan Jacob Givoni and Gelteq Pty Ltd
September 26, 2022Issued 746,268 fully paid Ordinary Shares to certain Australian investors who participated in the Pre-IPO Raise at an issue price of USD$1.34 per share.
February 5, 2023Date of Engagement Letter for the Provision of Chief Financial Officer and Professional Services by and among Vistra Australia Pty Ltd and Gelteq Ltd
January 23, 2023Date of Gelteq Authorised Licensee Agreement by and among Healthy Extracts Inc and Gelteq Ltd
January 23, 2023Date of Gelteq Authorised Licensee Agreement for 60,000 units of Whitney Johns Sugar Blocker (Orange) by and among Healthy Extracts Inc and Gelteq Ltd
January 23, 2023Date of Gelteq Authorised Licensee Agreement by and among Elbe Technologies Pty Ltd and Gelteq Ltd
May 5, 2023Board of directors approved the issuance of convertible notes to raise up to AUD$1,000,000.
October 3, 2023Closed the May 2023 Convertible Note offering raising approximately AUD$1,004,889.
February 2, 2024Board of directors approved the issuance of convertible notes to raise up to AUD$400,000.
February 1, 2024Date of Convertible Note Deed by and among Domalina Pty LTD ATF Domalina Unit Trust, Jeffrey Olyniec, Kircher International Holdings, Kircher Family Trusts dtd 3/24/04 and Gelteq Ltd.
February 2, 2024Date of Monash Innovation Labs Companies on Campus License Agreement by and among Monash University and Gelteq Ltd.
February 13, 2024Date of Consulting Agreement by and among Arc Group Limited and Gelteq Ltd.
March 26, 2024Closed the February 2024 Convertible Note offering raising approximately AUD$357,338.
May 25, 2024Date of Convertible Note Deed by and among Barabash Nominees Pty Ltd ATF Barabash Family Trust, Landis Testamentary Trust, Domalina Pty LTD ATF Domalina Unit Trust, Allan Cooper, Big Block Capital Group LLC and Gelteq Limited
May 27, 2024Board of directors approved the issuance of convertible notes to raise up to AUD$1,000,000.
September 9, 2024Date of Variation Agreement to the Consulting Agreement by and among Arc Group Limited and Gelteq Ltd.
September 24, 2024Date of filing Amendment No. 2 to Form F-1 registration statement.

Keywords

IPO, Gelteq Limited, Registration Statement, Underwriting Agreement, Ordinary Shares, Convertible Notes, Warrants, SEC, Initial Public Offering, Securities Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.